首页 | 本学科首页   官方微博 | 高级检索  
     


Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
Authors:Jung Hwan Yu  Young‐Joo Jin  Jin‐Woo Lee  Don‐Haeng Lee
Affiliation:1. Digestive Disease Center, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea;2. The National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorders (NCEED), Incheon, South Korea;3. Utah‐Inha Drug Delivery Systes and Advanced Therapeutics Research Center, Incheon, South Korea
Abstract:
Keywords:chronic hepatitis B  entecavir  hepatocellular carcinoma  tenofovir
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号